|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Thompson
CEO | Chief Executive Officer | 57 | - |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | ||
| +1.32% | +6.03% | +10.05% | +77.95% | 51.2B | ||
| +0.63% | -0.14% | +0.30% | +62.42% | 51.19B | ||
| -0.13% | +1.15% | +25.08% | +42.02% | 43.93B | ||
| +0.47% | +5.23% | +15.73% | +132.38% | 41.96B | ||
| +1.29% | -8.25% | +229.48% | +513.62% | 38.14B | ||
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | ||
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | ||
| +1.48% | +2.05% | +27.76% | +27.79% | 22.5B | ||
| Average | +0.80% | +0.14% | +46.23% | +109.46% | 41.37B | |
| Weighted average by Cap. | +0.86% | +0.04% | +44.55% | +110.68% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















